The Scientist

» drug development and disease/medicine

Most Recent

image: Cell Transplant Trial for Spinal Injury Is Safe

Cell Transplant Trial for Spinal Injury Is Safe

By Ruth Williams | June 1, 2018

The first human experiment with neural precursor cells implanted to treat chronic spinal cord injury suggests the procedure is safe, and hints at a small benefit.  

0 Comments

Understanding the factors that influence spillover could help forecast future epidemics.  

0 Comments

image: Predicting Future Zoonotic Disease Outbreaks

Predicting Future Zoonotic Disease Outbreaks

By Ashley Yeager | June 1, 2018

A step-by-step study of diseases that jump species gives subtle clues about future epidemics.

1 Comment

Doctors treated the fetus, who has alpha thalassemia major, with cells from her mother’s bone marrow.

0 Comments

Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.

0 Comments

image: Image of the Day: Jasper the Cat

Image of the Day: Jasper the Cat

By The Scientist Staff | May 22, 2018

Researchers found a previously undiscovered hepadnavirus in an immunocompromised cat.

0 Comments

image: Image of the Day: Hammerhead

Image of the Day: Hammerhead

By The Scientist Staff | May 21, 2018

This hammer-headed fruit bat is wearing a GPS tracker deployed by researchers with the Wildlife Conservation Society.

1 Comment

image: Immunotherapy More Effective in Men: Study

Immunotherapy More Effective in Men: Study

By Kerry Grens | May 18, 2018

Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.

0 Comments

image: FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

By Catherine Offord | May 17, 2018

Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.

0 Comments

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together real-world results.  

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. “Public” T-Cell Receptors From Resistant People Fend Off HIV